Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
563K
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
104K
-
Shares change
-
+104K
-
Total reported value, excl. options
-
$265K
-
Value change
-
+$265K
-
Number of buys
-
6
-
Price
-
$2.56
Significant Holders of Bluejay Diagnostics, Inc. - Common Stock (BJDX) as of Q4 2021
6 filings reported holding BJDX - Bluejay Diagnostics, Inc. - Common Stock as of Q4 2021.
Bluejay Diagnostics, Inc. - Common Stock (BJDX) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 104K shares
of 563K outstanding shares and own 18.4% of the company stock.
Largest 8 shareholders include VANGUARD GROUP INC (32.2K shares), JANE STREET GROUP, LLC (23.7K shares), PERKINS CAPITAL MANAGEMENT INC (22.5K shares), TWO SIGMA SECURITIES, LLC (15.8K shares), UBS Group AG (5.01K shares), BlackRock Inc. (4.35K shares), ADVISOR GROUP HOLDINGS, INC. (500 shares), and Tower Research Capital LLC (TRC) (227 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.